An exploration of the experience of dapagliflozin in clinical practice

Despite the availability of established treatments, heart failure (HF) is associated with a poor prognosis and suboptimal management, highlighting the need for new treatment and prevention options. It is suggested that sodium-glucose cotransporters 2 inhibitors can provide a beneficial therapeutic a...

Descripción completa

Detalles Bibliográficos
Autores principales: Anitha, Anuba Paulvarnan, Balasubramanian, Swetha, Ramalingam, Arun Gopal, Samuel Kennady, Shini Rubina, Ganamurali, Nila, Dhanasekaran, Dhivya, Sabarathinam, Sarvesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Future Science Ltd 2022
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9704035/
https://www.ncbi.nlm.nih.gov/pubmed/36457541
http://dx.doi.org/10.2144/fsoa-2022-0038

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9704035/
https://www.ncbi.nlm.nih.gov/pubmed/36457541
http://dx.doi.org/10.2144/fsoa-2022-0038

Ejemplares similares